Every call, on record
Asymmetric Investing by Travis Hoium on HIMS
“The stock I think looks extremely undervalued.”
“But you start to add things like peptides to that, now you could potentially be going to 5 billion, maybe $6 billion worth of revenue in the next couple of years. Now you're at the point where you're at a price to sales multiple of getting close to one. And if you do reach those kind of sales numbers, your growth rate is going to continue to be somewhere around this 50% rate. That's a growth rate that deserves a much higher multiple.”
“This is the kind of company that can not just 10x in value, but potentially 100x in value over the next 10, 20 years.”
“That could significantly increase”
“So I think this is the kind of company that could compound revenue 30 plus% over the course of 10 maybe even 20 years”
“Hims and Hers is one of the biggest positions, actually the biggest position today in that portfolio.”
“That's how you get to be a trillion dollar company. I think him and hers could potentially be that long term.”
“This is not a company that's going to have a market cap of $7 billion... This is going to be a company that's worth 10 times 100 times what it is today.”
“This is a multi-trillion dollar industry that Himm and Hers is the disruptor that the aggregator of demand that is potentially a trillion dollar business long-term.”
“I wouldn't be surprised to see that turnaround over the next few days and weeks.”
“I think they could do that by 2029, maybe even 2028 with a stretch goal, that's going to make this a great value stock and a growth stock.”
“People are going to be willing to pay for that, and that is going to drive the company's growth long-term.”
“I think we could see this past 4 million, maybe even 5 million subscribers in 2027.”
“Hims & Hers, one of those stocks and I'm building a position today, plan to hold that for the very long term.”
“Could be even more than that, another 20 years from now.”
“I think this easily could be over a $100 billion company a decade from now.”
“Again, this is a perfect asymmetric stock. This is either a company that's going to be worth a hundred billion, maybe even a trillion dollars 10 or 20 years from now, or it's going to be gone.”
“And if that's the case, if we get 50% plus growth and that's what they're guiding for for the second half of 2026, I think this company deserves to trade for a lot more than 3.3 times sales.”
“enterprise value to sales is just 3.4. This could easily be five times that, even 10 times that if the company picks up growth to 50% or more over the next year or two.”
“This is like I said the biggest holding in the asymmetric portfolio.”
“That's why this is the biggest holding in the Asymmetric portfolio today. I think this is one of the best risk-rewards on the market today.”
“That's how you get to be a 100X stock is winning around the globe, not just in one geography like the US. If Hims & Hers is able to become the global platform for healthcare, that is where this isn't just a $7.9 billion company. This is a trillion-dollar plus company.”
“So, you add all of that up and you look at a company trading for three and a half time sales. I think that is an absolute steal.”
“They might need to do that for the next decade because if they can grow 30 plus percent and compound that over the next decade, this is going to be a huge winner for investors.”